Evidence map›Paper›PMID 40656375›Full record

ArticleCureus2025

Zap-X Radiosurgery for Skull Base Meningiomas: A Long-Term Follow-Up Case Report.

Jingmin Bai, Jinyuan Wang, Chengcheng Wang, Xiangkun Dai, Wei Yu, Longsheng Pan, Baolin Qu

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jingmin BaiDepartment of Radiation Oncology, The First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, CHN.
Jinyuan WangDepartment of Radiation Oncology, The First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, CHN.
Chengcheng WangDepartment of Radiation Oncology, The First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, CHN.
Xiangkun DaiDepartment of Radiation Oncology, The First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, CHN.
Wei YuDepartment of Radiation Oncology, The First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, CHN.
Longsheng PanDepartment of Neurosurgery, The First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, CHN.
Baolin QuDepartment of Radiation Oncology, The First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, CHN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article reports two cases of meningioma patients treated with the novel radiosurgical device ZAP-X stereotactic radiosurgery. During the long-term follow-up period of up to four years after treatment, neither patient developed new neurological deficits, and no adverse reactions of Common Terminology Criteria for Adverse Events grade 2 or above occurred. By retrospectively analyzing the clinical diagnosis, treatment processes, and follow-up results of these two patients, this study aims to provide practical references for the large-scale clinical application of this technology.

Indexed as

long-term follow-upmeningiomasneurosurgeryradiosurgeryzap-x

Identifiers

PMID40656375
PMCPMC12254024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.